文献速递生殖医学

追踪质量:胚胎学关键绩效指标能否用于识别妊娠率中具有临床意义的偏移

Tracking quality: can embryology key performance indicators be used to identify clinically relevant shifts in pregnancy rate?
PubMed 文献 · Hum Reprod · 2019-01-01

该回顾性多中心研究分析了连续三个5个月期间共1971个新鲜IVF和ICSI周期的胚胎学关键绩效指标,期间培养液在中间期更换。结果显示第5天可用囊胚率在培养液更换后1周内从32%降至25%(P<0.0001),而临床妊娠率从51%降至36%在3个月后才被检出(P=0.0005);总可用囊胚率41%未受影响。

要点

  • 第5天可用囊胚率在培养液更换后1周内从32%降至25%(P<0.0001)。
  • 临床妊娠率从51%降至36%在D5BUR下降后3个月才被检出(P=0.0005)。
  • 总可用囊胚率41%未受培养液更换影响,全程在控制限内。

核心结论

  • 第5天可用囊胚率是重要的胚胎学关键绩效指标,能补充总可用囊胚率,在临床结局变化之前快速识别不良胚胎学结局。

研究设计与样本

  • 回顾性、多中心分析,纳入连续三个5个月期间(P1、P2和P3)共1971个新鲜IVF和ICSI周期,培养液在中间期更换。
  • 采用休哈特控制图对ICSI受精率、IVF受精率、D5BUR、TBUR和临床妊娠率进行月度追踪和统计过程控制分析。
  • 失控KPI通过警告限(2σ)和控制限(3σ)识别;采用单因素方差分析或Pearson卡方检验及逻辑回归分析培养液更换对胚胎学KPI和累积临床妊娠率的影响。

主要发现

  • 培养液更换后D5BUR从32%降至25%,在更换后1周内被检出(P<0.0001);更换回原培养液后D5BUR随后升高。
  • 培养液更换后临床妊娠率从51%降至36%,但在D5BUR偏移后3个月才被检出(P=0.0005)。
  • 培养液更换独立影响D5BUR、临床妊娠率和累积临床妊娠率。
  • TBUR(41%)未受培养液更换影响,在三个培养期间均保持在控制限内,提示仅凭总囊胚率可能不足以监测胚胎学实验室性能。

关键数值与推荐

  • D5BUR从32%降至25%(P<0.0001),临床妊娠率从51%降至36%(P=0.0005),TBUR为41%且未受影响。
  • 失控KPI通过警告限(2σ)和控制限(3σ)识别。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 当前研究展示的统计KPI监测系统在周期量较低的小型诊所中识别KPI偏移的效果可能较差。
  • 每启动周期活产率未纳入作为临床KPI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can embryology key performance indicators (KPIs) detect shifts in laboratory performance that precede changes in clinical outcomes? SUMMARY ANSWER: Day 5 usable blastocyst rate (D5BUR) is an important embryology KPI that complements total usable blastocyst rate (TBUR) in its ability to rapidly identify adverse embryology outcomes, prior to changes in clinical outcomes. WHAT IS KNOWN ALREADY: The hypothesis that monitoring performance of an IVF laboratory using statistical process controls (SPCs) can act as an early warning signal of shifts in laboratory conditions is a hypothesis that requires validation. The Vienna consensus report recently defined KPIs for monitoring fresh IVF and ICSI cycles, but the effectiveness of using these KPIs for detecting clinically relevant shifts following changes in laboratory processes is unknown. STUDY DESIGN, SIZE, DURATION: A retrospective, multicentre, analysis of KPIs for 1971 fresh IVF and ICSI cycles during three consecutive 5-month periods (P1, P2 and P3) during which the culture medium was changed in the middle period. PARTICIPANTS/MATERIALS, SETTING, METHODS: ICSI fertilisation rate, IVF fertilisation rate, D5BUR, TBUR and clinical pregnancy rate (CPR) were tracked monthly and analysed for SPC using Shewhart control charts. Out-of-control KPIs were identified by warning (2-sigma) and control (3-sigma) limits. The effect of the laboratory culture medium change on embryology KPIs and cumulative CPR was investigated using a one-way ANOVA or Pearson Chi-squared test and logistic regression. MAIN RESULTS AND THE ROLE OF CHANCE: D5BUR decreased from 32 to 25% after the culture medium was changed, and the decrease was detected within 1 week after the change (P < 0.0001). D5BUR subsequently increased after a change back to the original medium. A decrease in CPR (51-36%) after the medium change was also observed but was not detected until 3 months after the shift in D5BUR (P = 0.0005). Overall, the change in culture medium independently influenced D5BUR, CPR and cumulative CPR. Importantly, TBUR (41%) was not affected by the change in culture medium, remaining within control limits for all three culture periods, indicating that the overall blastocyst rate alone may not sufficiently monitor embryology laboratory performance. LIMITATIONS REASONS FOR CAUTION: The statistical KPI monitoring system demonstrated by the current study may be less effective at identifying KPI shifts in smaller clinics with lower cycle volumes. Live-birth rate per cycle started was not included as a clinical KPI. WIDER IMPLICATIONS OF THE FINDINGS: This study demonstrates that statistical KPI monitoring systems have the potential to provide systematic, early detection of adverse outcomes in ART laboratories after planned or unexpected shifts in conditions. STUDY FUNDING/COMPETING INTEREST(S): No external funds were used for the study. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hammond ER, Morbeck DE. Tracking quality: can embryology key performance indicators be used to identify clinically relevant shifts in pregnancy rate? Hum Reprod. 2019. PMID: 30517659. doi:10.1093/humrep/dey349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。